Wright Medical Group N.V. revised earnings guidance for the full year of 2019. For the period, the company is updating its previous net sales guidance range for full-year 2019 of approximately $954 million to $966 million and now anticipates net sales for full-year 2019 of approximately $925 million to $930 million, which includes $30 million from Cartiva.